Bringing LSPR Nanotechnology to In Vitro Diagnostics and Life Sciences
LamdaGen has developed a digital LSPR nanotechnology detection platform that enables diagnostic sensitivities and precise quantitation at levels far beyond the expected. Our patented nano-structured Localized Surface Plasmon Resonance technology (LSPR nanotechnology) produces highly robust biosensors in the form of metallic thin films that exhibit remarkable diagnostic detection capabilities into the low to sub-femtomolar range.
LamdaGen’s Plasmonic Platform technologies facilitate diagnostic detection limits into the low femtomolar range, over 4 logs more sensitive than conventional ELISA.
Ultra-sensitive and precisely quantitated diagnostics from a single sample drop in ~15 minutes – anywhere & anytime
Troponin I (cTnI) Ap Note: Read More ›
Platform for Next Generation Diagnostics: Read More ›
Plasmonic ELISA™
Ideally suited for In-Vitro and POC diagnostic systems, LamdaGen’s Plasmonic ELISA platform is precise, highly sensitive and rapid.
LightPath™ S4
LamdaGen’s LightPath S4 system performs highly sensitive label-free, real-time monitoring and characterization of biomolecular interactions.
LSPR Biosensors
LamdaGen’s metallic thin-film LSPR-based Optical Biosensors for research and development in the areas of Life Science and Cleantech.